Liechtenstein in the crypto spotlight: Bitcoin Suisse says Liechtenstein’s Financial Market Authority has granted it a MiCAR Crypto Asset Service Provider licence, giving the firm a regulated base to expand crypto services across selected EEA markets. EU health approvals with Liechtenstein reach: The European Commission approved Gilead’s Trodelvy as first-line monotherapy for metastatic triple-negative breast cancer (TNBC) for patients not eligible for PD-(L)1 inhibitors, and also backed MSD’s Keytruda plus Padcev for cisplatin-ineligible muscle-invasive bladder cancer—both explicitly covering Liechtenstein alongside EU states, Iceland and Norway. Cross-border security and justice: The European Commission proposed new measures to strengthen Europol and Eurojust mandates, revise the European Investigation Order, and adjust data rules to speed up cross-border prosecutions of serious crime and terrorism. Swiss policy pressure on foreigners: A Swiss parliamentary debate highlights proposals for “security” and “infrastructure” style fees targeting foreign residents, raising questions about compatibility with free-movement rules that include Liechtenstein-linked EFTA citizens. Climate and public services: Heatwave warnings expanded across Switzerland to level 4, while schools across Europe struggled to keep classrooms safe during extreme temperatures.